KEYNOTE-022 part 3: a randomized, double-blind, phase 2 study of pembrolizumab, dabrafenib, and trametinib in BRAF-mutant melanoma

por Antoni Ribas, Inge Marie Svane, Paolo Antonio Ascierto, Victoria Atkinson, Razi Ghori, Anna Maria Di Giacomo, Georgina V Long, Henrik Schmidt, Jacob Schachter, Eduard Gasal, Paola Queirolo, Michal Lotem, Michele Del Vecchio, Pier Francesco Ferrucci, Rosalie Stephens, Mahmoud Abu-Amna, Scott J Diede, Elizabeth S Croydon
Publicado 2020

A Natural Experiment Comparing the Effectiveness of the “Healthy Eagles” Child Weight Management Intervention in School Versus Community Settings

por Melissa Little, Shirley Serber-Souza, Maryam Kebbe, Paul N. Aveyard, Susan A. Jebb
Publicado 2021